发明申请
US20130156796A1 Method of Treatment of Tumors That Are Resistant to EGFR Therapies by EGFR Antibody Cytotoxic Agent Conjugate
有权
用EGFR抗体治疗抗EGFR疗法的肿瘤治疗方法细胞毒素偶联物
- 专利标题： Method of Treatment of Tumors That Are Resistant to EGFR Therapies by EGFR Antibody Cytotoxic Agent Conjugate
- 专利标题（中）： 用EGFR抗体治疗抗EGFR疗法的肿瘤治疗方法细胞毒素偶联物
-
申请号： US13682948申请日： 2012-11-21
-
公开(公告)号： US20130156796A1公开(公告)日： 2013-06-20
- 发明人: Julianto SETIADY , Peter U. Park , Thomas Chittenden
- 申请人： Julianto SETIADY , Peter U. Park , Thomas Chittenden
- 专利权人： ImmunoGen, Inc.
- 当前专利权人： ImmunoGen, Inc.
- 主分类号： A61K47/48
- IPC分类号： A61K47/48
摘要：
The present invention relates to the identification that EGFR antibody immunoconjugates are effective in inhibiting the growth of tumor cells that have developed EGFR and/or ALK resistance mechanisms. Methods of administering the EGFR antibody immunoconjugates to patients having resistant tumor cells is also disclosed.
公开/授权文献
信息查询
